Skip to content

Challenger® Ti-P

by Aesculap AG 2 variants

Ref PL579T

Active European Union

CE MDR

Valid until

7 Oct 2031

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier DNV MEDCERT GmbH

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number20201GB450260922 Date22 Sep 2026IssuedStatusActive expires 7 Oct 2031

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • 20201GB450260922 Active Reissued

    Technical documentation EU MDR

    Certifier
    DNV MEDCERT GmbH 0482
    Issued
    22 Sep 2026
    Expires
    7 Oct 2031
    Valid from
    8 Oct 2026

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
CHALLENGER Ti-P implant
Model / Reference
PL579T
Primary DI / UDI-DI
04046963356040
Basic UDI-DI
40392390000006832T
EMDN Code
H03020103 Reusable multiple clip appliers for videosurgery
Device Class
Class III
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
DE-MF-000005504

Other devices from Aesculap AG

See all devices from Aesculap AG →

Properties

  • Sterile
  • Implantable

Other properties (11)

  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No